Cost of sales of Jiangsu Hengrui Pharmaceuticals 2015-2022
In 2022, the overall cost of sales of Chinese pharmaceutical giant Jiangsu Hengrui Pharmaceuticals dropped by more than 21 percent to 7.35 billion yuan. More than half of the cost was spent on marketing, while almost 40 percent was spent on employee compensation and benefits.